Search details
1.
Unfermented ß-fructan Fibers Fuel Inflammation in Select Inflammatory Bowel Disease Patients.
Gastroenterology
; 164(2): 228-240, 2023 02.
Article
in English
| MEDLINE | ID: mdl-36183751
2.
STEP-CD study: ustekinumab use in paediatric Crohn's disease-a multicentre retrospective study from paediatric IBD Porto group of ESPGHAN.
Eur J Pediatr
; 2024 May 03.
Article
in English
| MEDLINE | ID: mdl-38700692
3.
Metabolome Changes With Diet-Induced Remission in Pediatric Crohn's Disease.
Gastroenterology
; 163(4): 922-936.e15, 2022 10.
Article
in English
| MEDLINE | ID: mdl-35679949
4.
IOIBD Recommendations for Clinical Trials in Ulcerative Proctitis: The PROCTRIAL Consensus.
Clin Gastroenterol Hepatol
; 20(11): 2619-2627.e1, 2022 11.
Article
in English
| MEDLINE | ID: mdl-35189386
5.
Outcomes and Predictors of Sustained Remission After Drug Withdrawal in Pediatric Crohn Disease.
J Pediatr Gastroenterol Nutr
; 75(5): 608-615, 2022 11 01.
Article
in English
| MEDLINE | ID: mdl-35976282
6.
Safety and Potential Efficacy of Escalating Dose of Ustekinumab in Pediatric Crohn Disease (the Speed-up Study): A Multicenter Study from the Pediatric IBD Porto Group of ESPGHAN.
J Pediatr Gastroenterol Nutr
; 75(6): 717-723, 2022 12 01.
Article
in English
| MEDLINE | ID: mdl-36084231
7.
Dietary Therapies Induce Rapid Response and Remission in Pediatric Patients With Active Crohn's Disease.
Clin Gastroenterol Hepatol
; 19(4): 752-759, 2021 04.
Article
in English
| MEDLINE | ID: mdl-32302709
8.
Moderate-to-severe Endoscopic Inflammation is Frequent After Clinical Remission in Pediatric Ulcerative Colitis.
J Pediatr Gastroenterol Nutr
; 72(4): 569-573, 2021 04 01.
Article
in English
| MEDLINE | ID: mdl-33346576
9.
The Effect of Nutritional Therapy on Bone Mineral Density and Bone Metabolism in Pediatric Crohn Disease.
J Pediatr Gastroenterol Nutr
; 72(6): 877-882, 2021 06 01.
Article
in English
| MEDLINE | ID: mdl-33587407
10.
Crohn's Disease Exclusion Diet Plus Partial Enteral Nutrition Induces Sustained Remission in a Randomized Controlled Trial.
Gastroenterology
; 157(2): 440-450.e8, 2019 08.
Article
in English
| MEDLINE | ID: mdl-31170412
11.
Dietary Guidance From the International Organization for the Study of Inflammatory Bowel Diseases.
Clin Gastroenterol Hepatol
; 18(6): 1381-1392, 2020 05.
Article
in English
| MEDLINE | ID: mdl-32068150
12.
Azithromycin and metronidazole versus metronidazole-based therapy for the induction of remission in mild to moderate paediatric Crohn's disease : a randomised controlled trial.
Gut
; 68(2): 239-247, 2019 02.
Article
in English
| MEDLINE | ID: mdl-29420227
13.
Evolving role of diet in the pathogenesis and treatment of inflammatory bowel diseases.
Gut
; 67(9): 1726-1738, 2018 09.
Article
in English
| MEDLINE | ID: mdl-29777041
14.
Global Variation in Use of Enteral Nutrition for Pediatric Crohn Disease.
J Pediatr Gastroenterol Nutr
; 67(2): e22-e29, 2018 08.
Article
in English
| MEDLINE | ID: mdl-29543696
15.
Nutrition in Pediatric Inflammatory Bowel Disease: A Position Paper on Behalf of the Porto Inflammatory Bowel Disease Group of the European Society of Pediatric Gastroenterology, Hepatology and Nutrition.
J Pediatr Gastroenterol Nutr
; 66(4): 687-708, 2018 04.
Article
in English
| MEDLINE | ID: mdl-29570147
16.
Which PCDAI Version Best Reflects Intestinal Inflammation in Pediatric Crohn Disease?
J Pediatr Gastroenterol Nutr
; 64(2): 254-260, 2017 02.
Article
in English
| MEDLINE | ID: mdl-27050050
17.
Reply.
Clin Gastroenterol Hepatol
; 19(6): 1297, 2021 06.
Article
in English
| MEDLINE | ID: mdl-33249018
18.
Efficacy of oral methotrexate in paediatric Crohn's disease: a multicentre propensity score study.
Gut
; 64(12): 1898-904, 2015 Dec.
Article
in English
| MEDLINE | ID: mdl-25416066
19.
Outcome measures for clinical trials in paediatric IBD: an evidence-based, expert-driven practical statement paper of the paediatric ECCO committee.
Gut
; 64(3): 438-46, 2015 Mar.
Article
in English
| MEDLINE | ID: mdl-24821616
20.
Levels of drug and antidrug antibodies are associated with outcome of interventions after loss of response to infliximab or adalimumab.
Clin Gastroenterol Hepatol
; 13(3): 522-530.e2, 2015 Mar.
Article
in English
| MEDLINE | ID: mdl-25066837